First Page | Meta Content | |
---|---|---|
Document Date: 2008-12-04 08:59:23Open Document File Size: 48,47 KBShare Result on FacebookCityStockholm / Kalamazoo / Brussels / /CompanyTherefore Pharmacia / Eli Lilly / The Upjohn Company / Solvay / Upjohns / AMP / R+D / Sandoz / Roche / Merck / Britannia/Orion / Pharmacia AB / Newco / Astra / Upjohn Inc. / Cyanamide / /ContinentEurope / Americas / /CountryGermany / Netherlands / Italy / Sweden / New Zealand / Norway / Belgium / France / Japan / Austria / United States / Australia / Portugal / Finland / Spain / Greece / /EventM&A / FDA Phase / /IndustryTermParkinson's treatment / oncology product / reasons pharmaceutical prices / important products / pharmaceutical industry / biotechnology products / health services / biotechnical products / disparate products / stroke treatment / pharmaceutical / medium sized pharmaceutical / pharmaceutical sales / pharmaceutical product markets / pharmaceutical products / chemicals / pharmaceutical firms / /MedicalConditionsolid tumours / HIV / neurological disorders / eye disorders / solid cancer / Parkinson's Disease / breast cancer / pancreatic cancer / Parkinson's / cancer / tumors / stroke / growth hormone deficiency / AIDS / infectious diseases / Cancer - solid tumours / tumours / /MedicalTreatmentantibiotics / /OrganizationSwedish Medical Products Agency / Office for Official Publications / European Communities L-2985 Luxembourg COMMISSION OF THE EUROPEAN COMMUNITIES Brussels / European Economic Community / U.S. Securities and Exchange Commission / European Union / European Medicines Evaluation Agency / / /Positionmarket leader / competitive player / /ProductEffexor / Rescriptor / Prozac / Kabikinase / Depo-Medrol / Cabergoline / Furthermore Reboxetine / Furthermore / /ProvinceOrStateMichigan / /Technologybiotechnology / /SocialTag |